Aralez Pharmaceuticals Inc. (ARLZ) has 27 open-market insider trades by 12 insiders since 2016. The most active filer is Arthur S. Kirsch, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| QLT Inc/bc | 10% Owner | — | 1 | $15.0M | 2016-03-17 |
| Jason Aryeh | Dir | — | 2 | $4.6M | 2017-05-23 |
| Robert Paul Harris | Dir | — | 3 | $2.0M | 2017-05-11 |
| Adrian Adams | CEO | — | 1 | $1.2M | 2017-05-11 |
| Andrew I. Koven | Pres | — | 4 | $1.0M | 2018-06-04 |
| Arthur S. Kirsch | Dir | — | 5 | $347K | 2017-12-08 |
| Seth Rudnick | Dir | — | 2 | $177K | 2017-05-11 |
| Scott J. Charles | CFO | — | 1 | $175K | 2017-07-28 |
| Mark A. Glickman | CCO | — | 1 | $92K | 2018-03-19 |
| James Patrick Tursi | Chief Medical Officer | — | 3 | $65K | 2018-05-14 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrew I. Koven | President | Sell | $116K | 2018-06-04 |
| Andrew I. Koven | President | Sell | $7K | 2018-05-14 |
| James Patrick Tursi | Chief Medical Officer | Sell | $5K | 2018-05-14 |
| Mark A. Glickman | Chief Commercial Officer | Sell | $10K | 2018-03-19 |
| James Patrick Tursi | Chief Medical Officer | Sell | $10K | 2018-03-19 |
| Eric Trachtenberg | Secretary & GC | Sell | $6K |
Companies that share insiders with ARLZ, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-03-19 |
| Andrew I. Koven | President | Sell | $17K | 2018-03-19 |
| Arthur S. Kirsch | Director | Buy | $74K | 2017-12-08 |
| James Patrick Tursi | Chief Medical Officer | Sell | $25K | 2017-10-02 |
| Scott J. Charles | CFO | Sell | $14K | 2017-07-28 |
| Eric Trachtenberg | Secretary & GC | Sell | $10K | 2017-06-23 |
| Arthur S. Kirsch | Director | Buy | $17K | 2017-06-15 |
| Arthur S. Kirsch | Director | Buy | $59K | 2017-06-14 |
| Andrew I. Koven | President | Sell | $414K | 2017-06-05 |
| Jason Aryeh | Director | Sell | $1.1M | 2017-05-19 |